Breakthrough dual fungicide technology could help prevent crop failures

via phys.org

An expert in environmental toxins at The University of Nottingham has developed a new antifungal technology which has the potential to play a major role in securing future food supplies.

Blocking fungal growth

Professor Simon Avery from the University’s Faculty of Medicine and Health Sciences has discovered that two agents, when combined, affect the process of protein synthesis, and have the potential to effectively block fungal growth in certain types of fungi which cause disease in crops or in humans.

Crop losses due to fungal spoilage each year are equivalent to the amount of food that could feed up to four billion people. In the developed world, millions of tonnes of crops are ruined each year by fungi and the problem is especially acute in developing countries where access to fungicides is more limited.

One of the problems with fungicides is that in many cases, the fungi adapt to the treatment, which means that most fungicides are only effective for a limited period. The solution developed by the University uses two agents which should make it more difficult for the fungi to acquire resistance to the fungicide.

Field trials

Explaining how the technology works, Professor Avery said: “Protein synthesis is essential to enable organisms to grow. When these two agents are applied it causes errors in the synthesis process that stop the fungus growing.”

After making the breakthrough discovery, which is patented by the University, Professor Avery and his team received initial development support through the University’s HERMES scheme. This enabled him to secure additional funding from the Biotechnology and Biological Science and Research Council (BBSRC) to further develop the technology. Field trials will take place this summer to study the impact of the fungicides on crops which are subjected to different environmental conditions.

The Latest on: Antifungal technology

via Google News

The Latest on: Antifungal technology

GST Council agrees to reduce GST on COVID vaccines to 5%
on June 12, 2021 at 5:50 am
GST Council on Saturday largely accepted the recommendations of the Group of Ministers constituted to look into extending the ambit of GST concessions on COVID treatment-related medical devices and ...
GST Council agrees to completely exempt antifungal drug Amphotericin-B, antiviral drug Tocilizumab from any kind of GST
on June 12, 2021 at 4:57 am
GST Council on Saturday largely accepted the recommendations of the Group of Ministers constituted to look into extending the ambit of GST concessions on COVID treatment-related medical devices and ...
Blueberry Therapeutics secures £750,000 investment from NPIF
on June 11, 2021 at 1:19 am
Maven Equity Finance, managed by Maven Capital Partners and part of the Northern Powerhouse Investment Fund has invested £750,000 in Blueberry Therapeutics Limited, a drug discovery and development ...
Antifungal Drug Market 2021 Definition, Size, Segments, Competitors Classification, Growth, Up and Down Stream Industry Analysis Forecast to 2026
on June 10, 2021 at 3:26 am
Jun 10, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry.” Global “Antifungal Drug Market” ...
CorMedix Inc. to Participate in Fireside Chat at the JMP Securities Life Sciences Conference
on June 9, 2021 at 5:30 am
CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today ...
Progress nailed on after drug discovery firm secures £750k funding package
on June 8, 2021 at 1:30 am
A Macclesfield drug discovery business has received a £750,000 funding injection to invest in trials for a new groundbreaking treatment for nail infections. NPIF-Maven Equity Finance, managed by Maven ...
This pharma firm in Gurugram first manufactured the drug that treats black fungus in India
on June 7, 2021 at 7:40 pm
Gurugram-based Lifecare Innovations has been working round the clock to meet the rising demand for Liposomal Amphotericin B that treats black fungus or mucormycosis.
Hospital Pharmacy Segment to Dominate India Anti-Fungal Drugs Market through FY2027 | TechSci Research
on June 6, 2021 at 6:02 am
Supportive government policies and rise of disposable income is expected to drive the demand for India anti fungal drugs market for the forecast period According to TechSci Research report India Anti ...
NovaBiotics Announces Publication of Data Elucidating NP339's Broad Antifungal Activity in Antimicrobial Agents and Chemotherapy
on June 1, 2021 at 3:48 am
Only three classes of antifungal agents are in mainstream clinical ... NovaBiotics' robust technology and business model has been validated through successful development from concept through ...
Anti-Fungal Drug Amphotericin-B Shortage Prevails In Maharashtra | Black Fungus | CNN News18
on May 20, 2021 at 9:16 pm
Anti-fungal drug Amphotericin-B shortage prevails in Maharashtra as the cases continue to rise.#Blackfungus #Latestnews #CNNNews18Subscribe our channel for latest ...